Literature DB >> 7249501

Amiloride-induced changes in digoxin dynamics and kinetics: abolition of digoxin-induced inotropism with amiloride.

S Waldorff, P B Hansen, H Kjaergård, J Buch, H Egeblad, E Steiness.   

Abstract

Digoxin dynamics and kinetics were studied in six healthy subjects with and without amiloride. Amiloride increased mean renal digoxin clearance from 1.3 to 2.4 ml . kg-1 . min-1 (p less than 0.001) due to increased tubular secretion of digoxin, while the glomerular filtration rate was unchanged. This might be caused by an increase in intracellular potassium concentration in the tubular cells provoked by amiloride. In contrast, the extrarenal clearance of digoxin was almost blocked by amiloride; it fell from a mean of 2.1 to 0.2 ml . kg-1 . min-1 (p less than 0.025). Total body clearance tended to fall, but the decrease was not statistically significant. EValuation of myocardial contractility by systolic time intervals revealed a concentration-response relationship between digoxin and changes in preejection period index when digoxin was given alone (rs = 0.750, p less than 0.001). Pretreatment with amiloride abolished this relationship (rs = 0.307, p = NS). Blood pressure and echocardiographically determined left ventricular end-diastolic diameter measurements indicated no changes in the left ventricular post- and preload. It is concluded that amiloride suppressed digoxin-induced inotropism.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7249501     DOI: 10.1038/clpt.1981.144

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  13 in total

Review 1.  Pharmacokinetic interactions with digoxin.

Authors:  S M Rodin; B F Johnson
Journal:  Clin Pharmacokinet       Date:  1988-10       Impact factor: 6.447

Review 2.  Clinical pharmacokinetic significance of the renal tubular secretion of digoxin.

Authors:  G Koren
Journal:  Clin Pharmacokinet       Date:  1987-11       Impact factor: 6.447

3.  The acute effects of amiloride and potassium canrenoate on digoxin-induced positive inotropism in healthy volunteers.

Authors:  J P Richter; D K Sommers; J R Snyman; S M Millard
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 4.  Indications for the measurement of plasma digoxin concentrations.

Authors:  J K Aronson
Journal:  Drugs       Date:  1983-09       Impact factor: 9.546

5.  Renal digoxin clearance: dependence on plasma digoxin and diuresis.

Authors:  E Steiness; S Waldorff; P B Hansen
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

6.  Effects of amiloride in guinea-pig and rat left atrial contraction as affected by frequency of stimulation and [Ca2+]0-[Na+]0 ratio: role of Na+/Ca2+ exchange.

Authors:  G Cargnelli; S Bova; S Luciani
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

7.  Amiloride improves hemodynamics in patients with chronic congestive heart failure treated with chronic digoxin and diuretics.

Authors:  M D Cheitlin; R Byrd; N Benowitz; E Liu; G Modin
Journal:  Cardiovasc Drugs Ther       Date:  1991-08       Impact factor: 3.727

8.  An electrophysiological study of amiloride on sino-atrial node cells and ventricular muscle of rabbit and dog.

Authors:  H Satoh; K Hashimoto
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-05       Impact factor: 3.000

Review 9.  Digoxin toxicity in the aged. Characterising and avoiding the problem.

Authors:  A P Passmore; G D Johnston
Journal:  Drugs Aging       Date:  1991 Sep-Oct       Impact factor: 3.923

Review 10.  Cardiac glycosides. Drug interactions of clinical significance.

Authors:  B Magnani; P L Malini
Journal:  Drug Saf       Date:  1995-02       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.